Southwest Oncology Group study of mitoxantrone for treatment of patients with advanced adenoid cystic carcinoma of the head and neck
โ Scribed by Douglas E. Mattox; Daniel D. Hoff; Stanley P. Balcerzak
- Book ID
- 104668721
- Publisher
- Springer US
- Year
- 1990
- Tongue
- English
- Weight
- 170 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
โฆ Synopsis
Eighteen patients are evaluable for response in a Phase II trial of Mitoxantrone for advanced adenoid cystic carcinoma of the head and neck. One patient had a complete response; there were no partial responses. Twelve patients had stable disease for 3 or more months. There was no significant anti-tumor activity of Mitoxantrone in the group of patients with adenoid cystic carcinoma, all of whom were previously heavily treated with surgery, chemotherapy and/or radiation therapy.
๐ SIMILAR VOLUMES
## Abstract ## Purpose. The purpose of this study was to analyze the results of radiotherapy (RT) alone or combined with surgery for adenoid cystic carcinoma. ## Methods. Between September 1966 and November 2001, 101 previously untreated patients were treated with curative intent with RT alone o
## Abstract ## Background. Squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) represent 2 clinically important subtypes of head and neck cancer. Our objective was to characterize and compare cytokine profiles in the systemic circulation of patients with SCC and ACC. ## Methods. Mul